4th Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
TTP TTIP TPA
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY KALBAUGH New | International Trade Counsel, Senate Finance Committee, Repub |
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Taxation/Internal Revenue Code TAX
Corporate tax reform OD Tax Credit Expiring tax provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY KALBAUGH | — |
| VANESSA PROCTER | — |
Copyright/Patent/Trademark CPT
Patent Reform (Goodlatte; Coons bills)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY KALBAUGH | — |
| VANESSA PROCTER | — |
Health Issues HCR
ACA Implementation 21st Century Cures Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY KALBAUGH | — |
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.